These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 12832125)

  • 1. Lipopeptides: adjuvanticity in conventional and genetic immunization.
    Mittenbühler K; v d Esche U; Heinevetter L; Bessler WG; Huber M
    FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):193-200. PubMed ID: 12832125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopeptide adjuvants in combination treatment.
    Bessler WG; Mittenbühler K; Esche Uv; Huber M
    Int Immunopharmacol; 2003 Aug; 3(8):1217-24. PubMed ID: 12860177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopeptides as immunoadjuvants and immunostimulants in mucosal immunization.
    Baier W; Masihi N; Huber M; Hoffmann P; Bessler WG
    Immunobiology; 2000 Jan; 201(3-4):391-405. PubMed ID: 10776795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
    BenMohamed L; Gras-Masse H; Tartar A; Daubersies P; Brahimi K; Bossus M; Thomas A; Druilhe P
    Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial lipopeptides constitute efficient novel immunogens and adjuvants in parenteral and oral immunization.
    Bessler WG; Baier W; vd Esche U; Hoffmann P; Heinevetter L; Wiesmüller KH; Jung G
    Behring Inst Mitt; 1997 Feb; (98):390-9. PubMed ID: 9382763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug specific antibodies: T-cell epitope-lipopeptide conjugates are potent adjuvants for small antigens in vivo and in vitro.
    Mittenbühler K; Loleit M; Baier W; Fischer B; Sedelmeier E; Jung G; Winkelmann G; Jacobi C; Weckesser J; Erhard MH; Hofmann A; Bessler W; Hoffmann P
    Int J Immunopharmacol; 1997 May; 19(5):277-87. PubMed ID: 9439766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-frequency ultrasound as a transcutaneous immunization adjuvant.
    Tezel A; Paliwal S; Shen Z; Mitragotri S
    Vaccine; 2005 May; 23(29):3800-7. PubMed ID: 15893617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial cell wall components as immunomodulators--I. Lipopeptides as adjuvants for parenteral and oral immunization.
    Bessler WG; Heinevetter L; Wiesmüller KH; Jung G; Baier W; Huber M; Lorenz AR; Esche UV; Mittenbühler K; Hoffmann P
    Int J Immunopharmacol; 1997; 19(9-10):547-50. PubMed ID: 9637352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic lipopeptides as novel adjuvants.
    Bessler WG; Jung G
    Res Immunol; 1992 Jun; 143(5):548-53; discussion 579-80. PubMed ID: 1439136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipopeptide derivatives of bacterial lipoprotein constitute potent immune adjuvants combined with or covalently coupled to antigen or hapten.
    Reitermann A; Metzger J; Wiesmüller KH; Jung G; Bessler WG
    Biol Chem Hoppe Seyler; 1989 Apr; 370(4):343-52. PubMed ID: 2757794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopeptide-polyoxyethylene conjugates as mitogens and adjuvants.
    Kleine B; Rapp W; Wiesmüller KH; Edinger M; Beck W; Metzger J; Ataulakhanov R; Jung G; Bessler WG
    Immunobiology; 1994 Feb; 190(1-2):53-66. PubMed ID: 8082887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcutaneous immunization by merely prolonging the duration of antigen presence on the skin of mice induces a potent antigen-specific antibody response even in the absence of an adjuvant.
    Naito S; Maeyama J; Mizukami T; Takahashi M; Hamaguchi I; Yamaguchi K
    Vaccine; 2007 Dec; 25(52):8762-70. PubMed ID: 18023509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant properties of bacterial product cantastim.
    Anghelache IF; Caras I; Salageanu A
    Roum Arch Microbiol Immunol; 2007; 66(1-2):17-21. PubMed ID: 18928058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helix pomatia hemocyanin - a novel bio-adjuvant for viral and bacterial antigens.
    Gesheva V; Chausheva S; Stefanova N; Mihaylova N; Doumanova L; Idakieva K; Tchorbanov A
    Int Immunopharmacol; 2015 May; 26(1):162-8. PubMed ID: 25799956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant effects of various lipopeptides and interferon-gamma on the humoral immune response of chickens.
    Erhard MH; Schmidt P; Zinsmeister P; Hofmann A; Münster U; Kaspers B; Wiesmüller KH; Bessler WG; Stangassinger M
    Poult Sci; 2000 Sep; 79(9):1264-70. PubMed ID: 11020070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunostimulation by bacterial components: I. Activation Of macrophages and enhancement of genetic immunization by the lipopeptide P3CSK4.
    vd Esche U; Ayoub M; Pfannes SD; Müller MR; Huber M; Wiesmüller KH; Loop T; Humar M; Fischbach KF; Strünkelnberg M; Hoffmann P; Bessler WG; Mittenbühler K
    Int J Immunopharmacol; 2000 Dec; 22(12):1093-102. PubMed ID: 11137616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-delivery of T helper 1-biasing cytokine genes enhances the efficacy of gene gun immunization of mice: studies with the model tumor antigen beta-galactosidase and the BALB/c Meth A p53 tumor-specific antigen.
    Tüting T; Gambotto A; Robbins PD; Storkus WJ; DeLeo AB
    Gene Ther; 1999 Apr; 6(4):629-36. PubMed ID: 10476222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal immunization with tetanus toxoid and CNF1 as a new mucosal adjuvant protects BALB/c mice against lethal challenge.
    Munro P; Flatau G; Lemichez E
    Vaccine; 2007 Dec; 25(52):8702-6. PubMed ID: 18035455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved immunogenicity of tetanus toxoid by Brucella abortus S19 LPS adjuvant.
    Mohammadi M; Kianmehr Z; Kaboudanian Ardestani S; Gharegozlou B
    Iran J Immunol; 2014 Sep; 11(3):189-99. PubMed ID: 25266004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The context of tetanus toxoid application influences the outcome of antigen-specific and self-directed humoral immune response.
    Stojanović M; Zivković I; Inić-Kanada A; Petrusić V; Mićić M; Dimitrijević L
    Microbiol Immunol; 2009 Feb; 53(2):89-100. PubMed ID: 19291092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.